Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities

This Viewpoint discusses the importance of studying coronavirus disease 2019 (COVID-19) vaccine candidates in prisoners, and proposes a framework for considering how to include them safely, ethically, and without coercion in future phase 3 vaccine trials.

Saved in:
Bibliographic Details
Published in:JAMA 2020-09, Vol.324 (11), p.1031-1032
Main Authors: Wang, Emily A, Zenilman, Jonathan, Brinkley-Rubinstein, Lauren
Format: Article
Language:English
Subjects:
Betacoronavirus
Clinical Trials, Phase III as Topic - ethics
Coronavirus Infections - prevention & control
Coronaviruses
COVID-19
COVID-19 Vaccines
Ethics
Humans
Medical ethics
Pandemics - prevention & control
Pneumonia, Viral - prevention & control
Prisoners
Prisons
SARS-CoV-2
Therapeutic Human Experimentation - ethics
United States
Vaccination - ethics
Vaccines
Viral diseases
Viral Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Viewpoint discusses the importance of studying coronavirus disease 2019 (COVID-19) vaccine candidates in prisoners, and proposes a framework for considering how to include them safely, ethically, and without coercion in future phase 3 vaccine trials.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2020.15589